Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12611000852954
ACTRN12611000852954
Completed
Phase 2

Randomised, double-blinded clinical trial comparing intranasal and intramuscular naloxone for reversal of suspected opioid overdose in clients of the Sydney Medically Supervised Injecting Centre

Sydney Medically Supervised Injecting Centre0 sites200 target enrollmentAugust 10, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSuspected acute opioid overdosePublic Health - Other public health

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Suspected acute opioid overdose
Sponsor
Sydney Medically Supervised Injecting Centre
Enrollment
200
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 10, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sydney Medically Supervised Injecting Centre

Eligibility Criteria

Inclusion Criteria

  • •All clients with symptoms/signs of an opioid overdose requiring Naloxone administration will be eligible for entry. This is based on existing and approved MSIC protocols and clinical criteria for overdose (reduced level of consciousness as measured by the Glasgow Coma Score, pinpoint pupils, respiratory depression and/or reduced oxygen saturations as measured by pulse oximetry).

Exclusion Criteria

  • •Less than 18 years of age
  • •Pregnant or suspected of being pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
A double-blind, randomized clinical trial comparing S-1 in combination with DC vaccine loaded with WT1 peptides (TLP0-001) or placebo for the patients with advanced pancreatic cancer refractory to standard chemotherapy.pancreatic cancer
JPRN-UMIN000027179Wakayama Medical University185
Recruiting
Not Applicable
TAP-studyElective mentally competent surgical patients for open inguinal hernia repair in daytime surgeryDe onderzoekspopulatie bestaat uit wilsbekwame proefpersonen ouder dan 18 jaar die zich op de preoperatieve screening van de polikliniek van de afdeling anesthesiologie in het Westfriesgasthuis presenteren voor een operatieve correctie van een liesbreuk volgens Lichtenstein en die voldoen aan de in en exclusie criteria zoals hieronder vermeld. De proefpersonen worden geïncludeerd na informed consent.
NL-OMON25473Westfries medical center Hoorn60
Completed
Not Applicable
A randomised, double blind clinical trial comparison the effect of a ultrasound-guided transversus abdominis plane (TAP) block and wound infiltration on postoperative pain (48h) for open inguinal hernia repair in day-carepost-operative pain after inguinal hernia repair10041297
NL-OMON42102Westfries Gasthuis60
Active, not recruiting
Phase 1
A trial on comparison the effect of a TAP-blok and wound-infiltration on pain after inguinal hernia repair surgeryPostoperative pain after hernia inguinalis repair surgeryMedDRA version: 17.0Level: LLTClassification code 10036236Term: Postoperative pain reliefSystem Organ Class: 100000004865Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2014-002595-82-NLWestfriesgasthuis
Active, not recruiting
Not Applicable
Double-blind, randomized, clinical trial to compare the efficacy and safety of diclofenc 3% gel vs. Solaraze 3% gel vs. vehicle for the treatment of patients with actinic keratosis.
EUCTR2011-003317-41-DEDermapharm AG